Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

NHS Awards Cytogenetics Tender to OGT

Published: Tuesday, February 04, 2014
Last Updated: Tuesday, February 04, 2014
Bookmark and Share
OGT has been awarded a significant tender by the UK National Health Service for the supply of oligo-based arrays for cytogenetics.

Involving the cooperation of a number of health authorities, the tender’s comprehensive validation process sets an excellent example for future procurement procedures. The resulting two-year agreement covers a consortium of four UK NHS Genetics Labs (Bristol, Manchester, Salisbury and Sheffield), with an additional eight labs (Birmingham, Cambridge, Cardiff, Great Ormond Street, Leeds, Leicester, Nottingham and Oxford) able to take advantage of the agreed supply framework. 

In order to assess the quality of the products, each Trust laboratory submitted a variety of samples for processing. OGT was successful against a number of alternative array providers with its CytoSure ISCA 8x60k platform, designed in collaboration with the International Collaboration for Clinical Genomics (ICCG)*, to deliver standardised, evidence-based designs to the cytogenetic research community. OGT was the only supplier whose product correctly identified all the genetic abnormalities tested. The success was attributed to a combination of the array and associated CytoSure Interpret Software performance, which delivers reliable and user-friendly data analysis, providing rapid access to meaningful results. This software is provided by OGT with all CytoSure arrays.

Leading the tender process was Mr Chris Wragg, BSc., FCRPath, Head of Molecular Cytogenetics at the Bristol Genetics Laboratory. He commented: “An exhaustive procurement and evaluation process was employed as, while we want to identify the most financially viable option, we can’t afford to compromise on quality. OGT was the only company able to deliver on quality, providing the best proposal, product and customer service. What we have achieved here is an excellent model for future procurements - it has delivered savings without compromising on quality.”

Dr Mike Evans, CEO of OGT said: “We are delighted with the result of this exceptionally well-run tender. It is a testament to our strong emphasis on not only the highest quality products and services but also customer support. We are pleased to continue our relationships with Bristol, Manchester, and Salisbury and are looking forward to welcoming Sheffield and the other Trusts to our group.”

*Formerly known as the International Standards for Cytogenomic Arrays (ISCA) Consortium.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Health Risks of Saturated Fats Aggravated by Immune Response
Research shows that the presence of saturated fats resulted in monocytes migrating into the tissues of vital organs.
Changing the Biological Data Visualisation World
Scientists at TGAC, alongside European partners, have created a cutting-edge, open source community for the life sciences.
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!